Inflammatory osteolysis in diabetic neuropathic (Charcot) arthropathies of the foot

Physical Therapy

Volumn 88, Issue 11, 2008, Pages 1399-1407

  Sinacore, David R ^a,b   Hastings, Mary K ^b   Bohnert, Kathryn L ^b   Fielder, Faye A ^b   Villareal, Dennis T ^b   Blair III, Vilray P ^c   Johnson, Jeffrey E ^b,d  

^a Program in Physical Therapy   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c West County Bone and Joint Associates   (United States)

^d Department of Orthopaedic Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; IMMOBILIZATION; MALE; NEUROPATHIC JOINT DISEASE; OSTEOLYSIS; SKIN TEMPERATURE;

ARTHROPATHY, NEUROGENIC; BONE DENSITY; CASE-CONTROL STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEITIS; OSTEOLYSIS; SEVERITY OF ILLNESS INDEX; SKIN TEMPERATURE; WEIGHT-BEARING;

EID: 55849142272     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.2522/ptj.20080025     Document Type: Article

References (43)

1. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29:736-746.
2. Thompson RC, Clohisy DR. Deformity following fracture in diabetic neuropathic osteoarthropathy. J Bone Joint Surg Am. 1993;75:1765-1773.
3. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307-310.
4. Sinacore DR. Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complications. 1998;12:287-293.
5. Eichenholtz SN. Charcot Joints. Springfield, Ill: Charles C Thomas, Publisher; 1966.
6. Diamond JE, Mueller MJ, Delitto A, Sinacore DR. Reliability of diabetic foot evaluation. Phys Ther. 1989;69:797-802.
7. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317-321.
8. Hologic Review. The Sahara Clinical Bone Sonometer: clinical use of T- and Z-scores. Available at: www.hologic.com. Accessed June 1, 2005.
9. Greenspan SL, Bouxsein ML, Melton ME, et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res. 1997;12:1303-1313.
10. Sinacore DR, Koger RC, Villareal DT, Strube MJ. Precision of serial quantitative ultrasonometry measures of the calcaneus [Abstract]. 2003. Available at: http://www.ptresearch.org/articles.htm.
11. DeLaet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis Int. 2005;16:1330-1338.
12. Obesity: preventing and managing the global epidemic. In: Report of a WHO Consultation on Obesity, June 3-5, 1997. Geneva, Switzerland: World Health Organization; WHO/NUT/NCD/98.1, i-xv, 1-276, 1998. Available at: http://dosei.who.int/uhtbin/cgisirsi/Wed+Nov+21+2.3:21:20+MET+2001/0/49. Accessed March 18, 2007.
13. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65:S147-S151.
14. Whiteside GT, Boulet JM, Sellers R, et al. Neuropathy-induced osteopenia in rats is not due to a reduction in weight borne on the affected limb. Bone. 2006;38:387-393.
15. Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000;2:33-37.
16. Kroot EJ, Nieuwenhuizen MG, de Waal Malefijt MC, et al. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum. 2001;44:1254-1260.
17. Compston JE, Vedi S, Croucher PI, et al. Bone turnover in non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1994;53:163-166.
18. Krempien B, Vulkicevic S, Vogel M, et al. Cellular basis of inflammation induced osteopenia in growing rats. J Bone Miner Res 1988;3:573-582.
19. Armour KJ, Armour KE, van't Hof RJ, et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum. 2001;44:2790-2796.
20. Young MJ, Marshall A, Adams JE, et al. Osteopenia, neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18:34-38.
21. Geusens P, Dequeker J, Verstraeten A, Nijs J. Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med. 1986;27:1540-1549.
22. Krolner B, Nielsen P. Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clin Sci. 1982;62:329-336.
23. Maluf KS, Mueller MJ. Comparison of physical activity and cumulative plantar tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clin Biomech (Bristol, Avon). 2003;18:567-575.
24. LeMaster JW, Mueller MJ, Reiber GE, et al. Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: Feet First randomized controlled trial. Phys Ther. 2008;88:1385-1398.
25. Deshpande AD, Dodson EA, Gorman I, Brownson RC. Physical activity and diabetes: opportunities for prevention through policy. Phys Ther. 2008;88:1425-1435.
26. Armstrong DG, Lavery LA. Acute Charcot's arthropathy of the foot and ankle. Phys Ther. 1998;78:74-80.
27. McCrory JL, Morag E, Norkitis AJ, et al. Healing rates of Charcot fractures: skin temperature and radiographic correlates. The Foot. 1998;8:158-165.
28. Piaggesi A, Rizzo L, Golia F, et al. Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract. 2002;58:1-9.
29. Commean PK, Ju T, Liu L, et al. Tarsal and metatarsal bone mineral density using volumetric quantitative computed tomography. J Digitial Imaging. In press.
30. Prior F, Commean PK, Ju T, et al. Developing a biomarker for neuropathic arthropathy in diabetic patients. Life Science Systems and Applications Workshop, 2007. USA 2007. IEEE/NIH. November 8-9, 2007. IEEE Xplore. Available at: http://ieeexplore.ieee.org/xpl/RecentCon.jsp?punumber=4400868&conhome= 1001257.
31. Mueller MJ, Zou D, Bohnert KL, et al. Plantar stresses on the neuropathic foot during barefoot walking. Phys Ther. 2008;88:1375-1384.
32. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513-521.
33. Sinacore DR. Severe sensory neuropathy need not precede Charcot arthropathies of the foot or ankle: implications for the rehabilitation specialist. Physiother Theory Pract. 2001;17:39-50.
34. Sinacore DR, Bohnert KL, Hastings MK, Johnson JE. Mid foot kinetics characterize structural polymorphism in diabetic foot disease. Clin Biomech (Bristol, Avon). 2007 June 27. [Epub ahead of print.)
35. Johnson JE. Charcot neuropathy of the foot: surgical aspects. In: Bowker JH, Pfeifer MA, eds. Levin & O'Neal's The Diabetic Foot. 6th ed. St Louis, Mo: Mosby Inc; 2001:587-606.
36. Physician's Guide to Prevention and Treatment for Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2003.
37. Kanis JA, and the WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int. 1994;4:368-381.
38. Guis S, Pellissier JF, Arniaud D, et al. Healing of Charcot's joint by pamidronate infusion. J Rheumatol. 1999; 26:1843-1845.
39. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomized controlled trial. Diabetologia. 2001;44:2032-2037.
40. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43:285-289.
41. Gasser JA. The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them. Curr Opin Pharmacol. 2006;6:313-318.
42. Hastings MK, Sinacore DR, Fielder FA, Johnson JE. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther. 2005;85:249-256.
43. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004;86:378-383.